chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a medical assistant refers to an unspecified patients of unknown age. On an unknown date from 28-JUL-2016 to 03-OCT-2016, the patients were vaccinated with improperly stored PNEUMOVAX 23 M005286, 08-OCT-2017 for 66 hours, previous excursion 10 centigrade for 10 hours, Time 0.89 centigrade. No adverse effects were reported. This is one of the several cases reported from the same reporter. Additional information has been requested.
p/vax pt neck pain; h/a; upper body achiness; arm discomfort at inj site;no treatment given
Pt had swelling and wheal at injection site. Reaction was measured 15mmx10mm.  Hot to the touch. Pt was instructed to notify treament facility of any problems.
As with the first dose,  my tongue was sore and blistered on the left side.  This lasted for just over a week.  There was also a hard, white spot on the inside of my cheek opposite the largest of the blisters, this lasted about three days. Unlike the first dose, my left arm (injection site) was very stiff and sore for a day. Also, unlike the first dose, there was little or no jaw pain.
Patient stated he normally has a small amount of blood when he blows his note and attributes it to the ASA he is on. Reported today that on Saturday (less than 24 hours after the vaccine) he had more bleeding than usual and wondered if it was vaccine related. No emergency room trip needed and bleeding stopped quickly.
Stomach cramps, painful digestion, dizziness, arm pain, memory problems, tiredness. buprofen for arm pain, works well, rest and water. Pepto Bismol for stomach cramps, helps slightly.
Sick; Body Aches; Sore Arm; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sick), MYALGIA (Body Aches) and PAIN IN EXTREMITY (Sore Arm) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 02FB21A and 040A21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced ILLNESS (Sick), MYALGIA (Body Aches) and PAIN IN EXTREMITY (Sore Arm). On 10-Apr-2021, ILLNESS (Sick), MYALGIA (Body Aches) and PAIN IN EXTREMITY (Sore Arm) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication use was unknown Treatment information was unknown
Information has been received from a registered nurse concerning a coworker who in "possibly" 1999 was vaccinated with a first and second dose of Varivax. In "possibly" 2003 the patient had a titer taken that was "low". There was no product quality complaint involved. Additional information has been requested.
Information has been received from a nurse concerning 3 female patients (the age of the patients ranged from 9 to 11 year old) who were vaccinated with a dose of Gardasil and fainted after being given the injection. Unspecified medical attention was sought by the patients. The outcome was unknown. Additional information has been requested.
Nausea, Headache, Fever, Sweats, Sore Arm
Patient reported feeling tingly.  It was reported in the arm within a few minutes of getting the vaccine.  He reported feeling it in the face as well.  I sat with the patient with benadryl available in case a histamine reaction occurred.  Patient never developed any rash and never had difficulty breathing.  Patient remained under supervision for 40 minutes after receiving the vaccine. He still said he didn't feel great but there was still no sign of a histamine reaction or anything.  Patient left the pharmacy feeling okay.  They took benadryl tablets and had instructions to call the hospital/dr. if they continued to feel unwell.
PFIZER COVID VACCINE #3 GIVEN 12/1/21, LOT #FG3527; pt with enterocolitis due to C. Diff from recent hospitalization; DNR; while in facility, pt had a positive COVID test; O2 supplementation; transitioned to comfort measures and pt passed away in SNF
Information has been received from a physician concerning a 74 year old male who on 20-JUN-2007 was vaccinated with a 0.65 ml first dose of Zostavax (Oka/Merck) (lot#657767/0740U).  On 12-JUL-2007 the patient developed a shingles outbreak.  It was noted that the patient had eight painless rashes on his leg and hip area.  Unspecified medical attention was sought.  No other information was provided.  There was no product quality complaint involved.  Additional information has been requested.
Patient developed headache that evening and woke up next day with worsening headache and nausea. Instructed to call family doctor.
Raised redness upper (L) thigh measuring 4 cm x 3 cm, area warm to touch, no tenderness when palpated.
Right deltoid with 3 in by 2.5 in area of erythema, edema and warmth to the touch, pin point area. Treatment is to apply cool compresses TID for 5 days and iboprofen.
This spontaneous report as received from a medical assistant refers to a patient of an unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On an unknown date, the patient was vaccinated with a properly stored but expired dose of Oka-Merck PROQUAD intramuscularly, lot # M042501, expiration date 17-APR-2018, (dose was not reported). No adverse effects were reported.
+3° fever, body aches, chills, lethargy lasted 24 hours. Diarrhea lasted 2 days.
UPPER LIP WAS SWOLLEN TO TWICE ITS NORMAL SIZE; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. Non-company suspect drugs included: diphenhydramine hydrochloride ( form of admin, route of admin, and batch number were not reported) dose, frequency, and therapy dates were not reported for swollen lips. No concomitant medications were reported. On an unspecified date, the subject experienced upper lip was swollen to twice its normal size. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of upper lip was swollen to twice its normal size was not reported. This report was non-serious.
COVID 19 Treatment; COVID 19 Treatment; Dose 1/Dose 2/ Dose 3/Dose 4: Moderna Covid-19 Vaccine; Dose 5: Pfizer; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 71-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 12Sep2022 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 70 years, in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 05Mar2021 as dose 1, single (Batch/Lot number: unknown), in left arm, on 02Apr2021 as dose 2, single (Batch/Lot number: unknown), in left arm, on 30Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm and on 05Apr2022 as dose 4 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 12Sep2022, outcome "unknown", described as "Dose 1/Dose 2/ Dose 3/Dose 4: Moderna Covid-19 Vaccine; Dose 5: Pfizer"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "recovering" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jan-2021 at 2:04 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 07-Jan-2021 at 2:04 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 78.04.  Concomitant products were not provided.  On 07-Jan-2021, Excursion time was 9 AM and 10 AM temperature was 34, total doses given for the day was 96. Condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 05-Jan-2021, vial was moved to clinic on 07-Jan-2021. 6 vials were sent to clinic. Vaccine BUD date was 27-Jan-2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
Developed pain under the eyes, in the site where dermal filler had previously been injected. Painful to the touch. No swelling or redness observed. No treatment seeked up to the moment of reporting.
Weakness; headache similar to her migraine headaches; arm also swelled up and got red at the injection site; arm also swelled up; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weakness), HEADACHE (headache similar to her migraine headaches), VACCINATION SITE ERYTHEMA (arm also swelled up and got red at the injection site) and VACCINATION SITE SWELLING (arm also swelled up) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     Concurrent medical conditions included Migraine headache, Cholesterol (Cholesterol medicine 400 mg) and Thyroid disorder NOS (Thyroid medicine). Concomitant products included SERTRALINE HYDROCHLORIDE (ZOLOFT), TRAZODONE and AMITRIPTYLINE HYDROCHLORIDE (ELAVIL [AMITRIPTYLINE HYDROCHLORIDE]) for an unknown indication.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced ASTHENIA (Weakness), HEADACHE (headache similar to her migraine headaches), VACCINATION SITE ERYTHEMA (arm also swelled up and got red at the injection site) and VACCINATION SITE SWELLING (arm also swelled up). On 10-Mar-2021, HEADACHE (headache similar to her migraine headaches) had resolved. On 15-Mar-2021, ASTHENIA (Weakness) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (arm also swelled up and got red at the injection site) and VACCINATION SITE SWELLING (arm also swelled up) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications also included unspecified medications for cholesterol and thyroid.   Treatment information was not provided by reporter.   This case was linked to MOD-2021-074885 (Patient Link).
Headache, Myalgia, Chills, edema (L upper extremity)
mom devel chicken pox like rash on hands & feet subsequent to her twin children having similar exposure following vax;
tested positive for SARS-CoV2 on 6/14/2021 , asymptomatic, tested routinely for admission to a sub-acute rehab facility per that facility's rules
EXPIRED VACCINE ADMINISTERED; This spontaneous report received from a pharmacist concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. Batch number was not reported and has been requested. No concomitant medications were reported. On 2021, the subject experienced expired vaccine administered. The action taken with covid-19 vaccine  was not applicable. The outcome of expired vaccine administered was not reported. This report was non-serious.
The patient received a tetanus vaccine on 08/25/05 and states she experienced, weakness, dizziness, fever and chills for approximately two days. She states she had to remain in bed. Three days later at her follow-up visit she stated her symptoms had subsided and no treatment was necessary.
Today, February 4, My injection site has swollen, turned red and itches 2 weeks after my injection.   At the time of injection it was very slightly sore and barely red. It became more sore the day after the shot and then settled down with nothing happening on my arm. I did had a slight headache but it also went away. It was never as swollen and red a itchy as it is now.  I also awoke early this morning with a mild headache. I have some congestion also. I took some actives an hour ago hoping it will help.
ACUTE NON ST ELEVATION MI ACUTE MI 9/18/2022,  9/20/2022,  11/11/2022,  2/9/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Initially there was no reaction, just a sore arm for one day.  On day 7, weals started appearing on chest and arm, and have subsided.  This is day 10, and the injections site is iching, red, warm and hard.
4/1 9:00 pm began to have chills and feel achy. Took 2 Tylenol. 4/2 8:00 am  woke with headache  body aches  fever 100.3 Took 2 Advil. 4/2 12:00 pm headache  temp 99.4 4/2  5:00 pm headache temp 100.4 4/2 9:00 pm 99.4  Took 2 Advil. 4/3 11:00 am Headache 100.3  Took 2 Tylenol  4/3  1:00 pm 100.2 Headache  injection site itchy and bruised 4/3 3:00 pm Headache much worse temp 99.1 4/3 7:00pm Temp 100.3 headache injection site red and swollen. Took 2 Advil 4/4 10:00 am Temp 97.6   No headache injection site slightly bruised and red. Breast tenderness
Redness, swelling at site, 4 days after admit: 14 1/2 cm x 12 1/2 cm.
pt vaxed on 28JUN93 devel unlateral deafness p/vax; sx occured 45 day post vax; pt treated w/Pred & recovered completely;
On 12/31/2020 patient received her 1st dose of Covid vaccine while she was on her 4th day of antibiotics to treat a UTI.  On 1/6/2021, patient started to have a rash and experience difficulty breathing.  Patient went to ER and her antibiotics was changed.  Patient has not had a reaction to either antibiotics in the past.  This may be a duplicate submission, but did not receive an email confirmation so I am resubmitting.
Shivering, nausea, vomiting, diarrhea and pain in hips and thigh regions. Duration into 5:00 AM when able to fall asleep. Tried Aspirin and Advil with no relief.
Left arm is painful in the area of shot 9 days after the shot, can't put any pressure on it, can't sleep on it. VERY SORE ARM and there is weakness in the arm to lift.
fever, nausea, vomiting, dry heaving, body soreness; fever, nausea, vomiting, dry heaving, body soreness; fever, nausea, vomiting, dry heaving, body soreness; fever, nausea, vomiting, dry heaving, body soreness; fever, nausea, vomiting, dry heaving, body soreness; This is a spontaneous report from a non-contactable consumer (patient herself). A 33-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: unknown, expiry date: unknown) via unspecified route of administration on an unspecified date in Mar2021, (age at vaccination: 33-years) a dose number unknown single. Patients medical history and concomitant medications were not reported. No other vaccines were administered to patient in four weeks. On 11Mar2021, patient experienced fever, nausea, vomiting, dry heaving, body soreness. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. The outcome of events was recovered on an unspecified date in Mar2021.   No follow-up attempts are possible; information about lot/batch number cannot been obtained
Diffuse rash/redness below the injection site. Painful to touch. Not so itchy. This rash/redness started on Day 6 after the vaccine was received. Day 11 and it is still visible. No signs of improvement. Also delayed reaction noted on Day 6 & 7 after vaccine (chills, body ache and arm L was still hurting). Immediate side effects hours after were headache, nausea and pain at injection site/whole arm.
Intense headache by evening of the day of injection lasting until next morning - ingested one dose of OTC pain medication; Flu-like symptoms (body aches, lethargy, loss of appetite) the next day lasting for 3.5 days - no treatment administered; Persistent cough (no mucus) for 18 days - no treatment administered
Feeling unwell, such as when one is coming down with flu/cold at the start of day and by the end of the day, her entire body ached like that caused by the flu; Feeling unwell, such as when one is coming down with flu/cold at the start of day and by the end of the day, her entire body ached like that caused by the flu; This is a spontaneous report from contactable other healthcare professional (patient herself). A 29-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Solution for injection (lot number and expiry date unknown) via an unspecified route of administration at the left arm on 03Jan2021, 10:00AM at a single dose for COVID-19 immunization. The patient had no medical history and had no known allergies to medications, food, or other products. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to BNT162B2. The patient did not receive other medications within two weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 04Jan2021, 07:00 AM, the patient experienced feeling unwell, such as when one is coming down with flu/cold at the start of day and by the end of the day (no time reported), her entire body ached like that caused by the flu. No treatment was received for the events. Outcome of the events at the time of last observation in Jan2021 was reported as recovered. The report was assessed as non-serious; the events did not result in death, were not life threatening, did not caused/prolonged hospitalization, were not disabling/ incapacitating, and did not caused any congenital anomaly/birth defect.  Information on the batch/lot number has been requested.
around 14 minutes after administration, pt c/o lightheadedness. denied chest pain. provided with water, juice and crackers, which pt consumed and reported feeling better.
Day after shot, end of all patient's fingers turned yellow then purple and were numb. Left hand was worse than right (had rec'd injection in left arm). Patient had chills for 2 hours. Purple fingers went away after the second day. Numbness lasted for 3 days then went away.  Numbness continues to come back every few days and lasts 1 to 2 hours (worse in thumbs, mostly the left).  No purpleness.  Patient called his MD the day after the shot.  MD told him to soak in a warm bath, which he said did help some.
Light headed, felt faint.  Vitals remained stable.  Did need to lay down for approximately 30 min. then sent to ED for evaluation
In 1973, I was tested for egg allergy, because I became nauseated, broke out in hives, skin became blotchy all over, I was told never to take a flu shot and was given a red dog tag at that time. Now at the age of 54 I am still very allergic to eggs and have never taken a flu shot. I was given a shot of Benadryl immediately for the reaction. I have always gone to the Medical Center for all my health care, and each year have regular check-ups. I am also allergic to shellfish, erythromycin, aspirin and codeine.
The second dose, I had my head was hurting on yesterday;  I wake up this morning my whole body is aching and fever and chills and my head hurts real bad; The second dose, I had my head was hurting on yesterday;  I wake up this morning my whole body is aching and fever and chills and my head hurts real bad; The second dose, I had my head was hurting on yesterday;  I wake up this morning my whole body is aching and fever and chills and my head hurts real bad; The second dose, I had my head was hurting on yesterday;  I wake up this morning my whole body is aching and fever and chills and my head hurts real bad; This is a spontaneous report from a contactable consumer or other non-health care professional (patient). A 47-year-old female patient received bnt162b2 (BNT162B2, Solution for injection, Lot Number: EW0187) via an unspecified route of administration, administered in left arm on 26May2021 (at the age of 47-year-old) as dose 2, single for covid-19 immunization. Medical history included blood pressure high, outdoor allergies/allergies from an unknown date and unknown if ongoing. Concomitant medications included cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) taken for allergies, start and stop date were not reported. Historical vaccine included BNT162B2 (BNT162B2, solution for injection, Lot number: EW0167) via an unspecified route of administration in left arm, administered on 05May2021 (at the age of 47-year-old) as dose 1, single for COVID-19 immunization. On an unspecified date the patient reported after the second dose, her head was hurting on yesterday; she woke up in morning her whole body was aching and fever and chills and her head hurted really bad. Outcome of the events were unknown.